TaTME | Ricerc@Sapienza

Quality of Life in Rectal Cancer Treated by Endoluminal Loco-Regional Resection by Tem Vs Laparoscopic Total Mesorectal Excision: Long Term Results

Background:
Endoluminal loco-regional resection (ELRR) by transanal endoscopic
microsurgery (TEM) may be an alternative treatment option to laparoscopic total
mesorectal excision (LTME), in selected patients with N0 rectal cancer. Post-operative
Quality of Life (QoL) evaluation is an important parameter of outcomes related to high
percentage of functional sequelae. We reported, in a previous published paper, the short and
medium term results of QoL in patients underwent ELRR by TEM or LTME.
Aim:

An international multicentre prospective audit of elective rectal cancer surgery. Operative approach versus outcome, including transanal total mesorectal excision (TaTME)

Introduction: Transanal total mesorectal excision (TaTME) has rapidly emerged as a novel approach for rectal cancer surgery. Safety profiles are still emerging and more comparative data is urgently needed. This study aimed to compare indications and short-term outcomes of TaTME, open, laparoscopic, and robotic TME internationally. Methods: A pre-planned analysis of the European Society of Coloproctology (ESCP) 2017 audit was performed.